Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John N Hathcock

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA|March 21, 2002
Does high intake of vitamin A pose a risk for osteoporotic fracture?John N Hathcock
JAMA|February 25, 2003
Vitamins and hormone therapy for coronary atherosclerosisJohn N Hathcock
Regulatory Toxicology and Pharmacology : RTP|August 12, 2006
Risk assessment for carnitineJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|September 1, 2006
Risk assessment for glucosamine and chondroitin sulfateJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for the carotenoids lutein and lycopeneAndrew Shao, John N Hathcock
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for coenzyme Q10 (Ubiquinone)John N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for creatine monohydrateAndrew Shao, John N Hathcock
The Journal of Nutrition|September 23, 2008
Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substancesJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|March 8, 2008
Risk assessment for the amino acids taurine, L-glutamine and L-arginineAndrew Shao, John N Hathcock
The American Journal of Clinical Nutrition|January 9, 2007
Risk assessment for vitamin DJohn N Hathcock, Andrew Shao, Reinhold Vieth, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA|March 21, 2002
Does high intake of vitamin A pose a risk for osteoporotic fracture?John N Hathcock
JAMA|February 25, 2003
Vitamins and hormone therapy for coronary atherosclerosisJohn N Hathcock
Regulatory Toxicology and Pharmacology : RTP|August 12, 2006
Risk assessment for carnitineJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|September 1, 2006
Risk assessment for glucosamine and chondroitin sulfateJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for the carotenoids lutein and lycopeneAndrew Shao, John N Hathcock
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for coenzyme Q10 (Ubiquinone)John N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|July 4, 2006
Risk assessment for creatine monohydrateAndrew Shao, John N Hathcock
The Journal of Nutrition|September 23, 2008
Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substancesJohn N Hathcock, Andrew Shao
Regulatory Toxicology and Pharmacology : RTP|March 8, 2008
Risk assessment for the amino acids taurine, L-glutamine and L-arginineAndrew Shao, John N Hathcock
The American Journal of Clinical Nutrition|January 9, 2007
Risk assessment for vitamin DJohn N Hathcock, Andrew Shao, Reinhold Vieth, et al.
Pageof 2